113 related articles for article (PubMed ID: 25104222)
1. Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells.
Liu X; Chen D; Liu G
Biosci Biotechnol Biochem; 2014; 78(11):1895-901. PubMed ID: 25104222
[TBL] [Abstract][Full Text] [Related]
2. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
Liu X; Chen D; Liu J; Chu Z; Liu D
Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
[TBL] [Abstract][Full Text] [Related]
3. Vincristine promotes migration and invasion of colorectal cancer HCT116 cells through RhoA/ROCK/ Myosin light chain pathway.
Jin X; Liu K; Jiao B; Wang X; Huang S; Ren W; Zhao K
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):91-96. PubMed ID: 27894406
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
He M; Cheng Y; Li W; Liu Q; Liu J; Huang J; Fu X
BMC Cancer; 2010 Apr; 10():170. PubMed ID: 20429915
[TBL] [Abstract][Full Text] [Related]
5. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
6. The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.
Dulong C; Fang YJ; Gest C; Zhou MH; Patte-Mensah C; Mensah-Nyagan AG; Vannier JP; Lu H; Soria C; Cazin L; Mei YA; Varin R; Li H
Int J Oncol; 2014 Feb; 44(2):539-47. PubMed ID: 24337141
[TBL] [Abstract][Full Text] [Related]
7. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
[TBL] [Abstract][Full Text] [Related]
8. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
Hou C; Zhuang Z; Deng X; Xu Y; Zhang P; Zhu L
Oncol Rep; 2018 Feb; 39(2):795-801. PubMed ID: 29207149
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between expression of RhoA and Rho kinase in uterine smooth muscle and the onset of labor].
Gao J; Ding YL
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):345-9. PubMed ID: 19573309
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
12. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
Yan L; Li H; An W; Wei W; Zhang X; Wang L
Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
[TBL] [Abstract][Full Text] [Related]
13. Metabolites of intestinal microflora upregulate miR-192-5p to suppress proliferation of colon cancer cells via RhoA-ROCK-LIMK2 pathway.
Huang YL; Li XH; Ma H; Yue HY; Hu XY
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1794-1806. PubMed ID: 32141548
[TBL] [Abstract][Full Text] [Related]
14. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
15. [Modulation of RhoA/Rho kinase on migration, invasion and proliferation of fibroblast like synoviocytes from patients with rheumatoid arthritis].
Liang LQ; Huang MC; Qiu Q; Xiao YJ; Sun MY; Zhan ZP; Ye YJ; Fan JJ; Yang XY; Xu HS
Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1345-8. PubMed ID: 24029487
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor 7 promotes tumor migration and invasiveness via the RhoA/ROCK pathway in metastatic squamous cell carcinoma of the head and neck.
Xu Z; Zheng X; Yang L; Liu F; Zhang E; Duan W; Bai S; Safdar J; Li Z; Sun C
Oncol Rep; 2015 Feb; 33(2):849-55. PubMed ID: 25434638
[TBL] [Abstract][Full Text] [Related]
18. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
19. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
